42.04 USD
-1.52 (-3.49%)
42 USD
-0.04 (-0.1%)
VCYT gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 528 industry peers in the Biotechnology industry. VCYT has an excellent financial health rating, but there are some minor concerns on its profitability. VCYT is growing strongly while it is still valued neutral. This is a good combination! These ratings would make VCYT suitable for growth investing!
1. Profitability
1.1 Basic Checks
In the past year VCYT was profitable.
In the past year VCYT had a positive cash flow from operations.
VCYT had negative earnings in 4 of the past 5 years.
In multiple years VCYT reported negative operating cash flow during the last 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of 2.21%, VCYT belongs to the top of the industry, outperforming 89.25% of the companies in the same industry.
VCYT's Return On Equity of 2.40% is amongst the best of the industry. VCYT outperforms 90.19% of its industry peers.
VCYT's Return On Invested Capital of 2.96% is amongst the best of the industry. VCYT outperforms 90.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.21% | ||
| ROE | 2.4% | ||
| ROIC | 2.96% |
ROA(3y)-2.65%
ROA(5y)-4.39%
ROE(3y)-2.82%
ROE(5y)-4.73%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
VCYT's Profit Margin of 6.10% is amongst the best of the industry. VCYT outperforms 90.00% of its industry peers.
With an excellent Operating Margin value of 9.81%, VCYT belongs to the best of the industry, outperforming 91.51% of the companies in the same industry.
Looking at the Gross Margin, with a value of 68.53%, VCYT belongs to the top of the industry, outperforming 81.13% of the companies in the same industry.
VCYT's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9.81% | ||
| PM (TTM) | 6.1% | ||
| GM | 68.53% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.39%
GM growth 5Y-0.79%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so VCYT is destroying value.
The number of shares outstanding for VCYT has been increased compared to 1 year ago.
VCYT has more shares outstanding than it did 5 years ago.
There is no outstanding debt for VCYT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
VCYT has an Altman-Z score of 18.51. This indicates that VCYT is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 18.51, VCYT belongs to the best of the industry, outperforming 87.74% of the companies in the same industry.
There is no outstanding debt for VCYT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 18.51 |
ROIC/WACC0.34
WACC8.82%
2.3 Liquidity
VCYT has a Current Ratio of 6.24. This indicates that VCYT is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 6.24, VCYT is in the better half of the industry, outperforming 63.96% of the companies in the same industry.
VCYT has a Quick Ratio of 5.96. This indicates that VCYT is financially healthy and has no problem in meeting its short term obligations.
VCYT's Quick ratio of 5.96 is fine compared to the rest of the industry. VCYT outperforms 63.40% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 6.24 | ||
| Quick Ratio | 5.96 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 353.33% over the past year.
Looking at the last year, VCYT shows a quite strong growth in Revenue. The Revenue has grown by 16.41% in the last year.
Measured over the past years, VCYT shows a very strong growth in Revenue. The Revenue has been growing by 29.93% on average per year.
EPS 1Y (TTM)353.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%26.32%
Revenue 1Y (TTM)16.41%
Revenue growth 3Y26.64%
Revenue growth 5Y29.93%
Sales Q2Q%13.82%
3.2 Future
VCYT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 51.21% yearly.
VCYT is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.52% yearly.
EPS Next Y76.8%
EPS Next 2Y87.27%
EPS Next 3Y59.79%
EPS Next 5Y51.21%
Revenue Next Year14.5%
Revenue Next 2Y12.7%
Revenue Next 3Y12.38%
Revenue Next 5Y11.52%
3.3 Evolution
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 110.63 indicates a quite expensive valuation of VCYT.
Based on the Price/Earnings ratio, VCYT is valued cheaply inside the industry as 89.62% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of VCYT to the average of the S&P500 Index (27.19), we can say VCYT is valued expensively.
Based on the Price/Forward Earnings ratio of 39.96, the valuation of VCYT can be described as expensive.
Based on the Price/Forward Earnings ratio, VCYT is valued cheaply inside the industry as 91.51% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.92, VCYT is valued quite expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 110.63 | ||
| Fwd PE | 39.96 |
4.2 Price Multiples
VCYT's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. VCYT is cheaper than 91.70% of the companies in the same industry.
VCYT's Price/Free Cash Flow ratio is rather cheap when compared to the industry. VCYT is cheaper than 93.96% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 33.82 | ||
| EV/EBITDA | 41.18 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
VCYT has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as VCYT's earnings are expected to grow with 59.79% in the coming years.
PEG (NY)1.44
PEG (5Y)N/A
EPS Next 2Y87.27%
EPS Next 3Y59.79%
5. Dividend
5.1 Amount
No dividends for VCYT!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
42.04
-1.52 (-3.49%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)
Earnings (Next)
Inst Owners114.83%
Inst Owner Change-0.02%
Ins Owners0.42%
Ins Owner Change-3.94%
Market Cap3.32B
Revenue(TTM)495.14M
Net Income(TTM)30.18M
Analysts82.11
Price Target49.33 (17.34%)
Short Float %6.68%
Short Ratio5.63
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-15.65%
Min EPS beat(2)-110.32%
Max EPS beat(2)79.03%
EPS beat(4)2
Avg EPS beat(4)-1.91%
Min EPS beat(4)-110.32%
Max EPS beat(4)79.03%
EPS beat(8)5
Avg EPS beat(8)108.97%
EPS beat(12)8
Avg EPS beat(12)67.3%
EPS beat(16)12
Avg EPS beat(16)58.01%
Revenue beat(2)2
Avg Revenue beat(2)4.54%
Min Revenue beat(2)3.31%
Max Revenue beat(2)5.76%
Revenue beat(4)3
Avg Revenue beat(4)2.42%
Min Revenue beat(4)-0.39%
Max Revenue beat(4)5.76%
Revenue beat(8)7
Avg Revenue beat(8)4.03%
Revenue beat(12)11
Avg Revenue beat(12)4.6%
Revenue beat(16)15
Avg Revenue beat(16)5.32%
PT rev (1m)0%
PT rev (3m)17.32%
EPS NQ rev (1m)0%
EPS NQ rev (3m)14.94%
EPS NY rev (1m)1.3%
EPS NY rev (3m)40.54%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.48%
Revenue NY rev (1m)0.12%
Revenue NY rev (3m)1.47%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 110.63 | ||
| Fwd PE | 39.96 | ||
| P/S | 6.71 | ||
| P/FCF | 33.82 | ||
| P/OCF | 30.77 | ||
| P/B | 2.64 | ||
| P/tB | 8.33 | ||
| EV/EBITDA | 41.18 |
EPS(TTM)0.38
EY0.9%
EPS(NY)1.05
Fwd EY2.5%
FCF(TTM)1.24
FCFY2.96%
OCF(TTM)1.37
OCFY3.25%
SpS6.26
BVpS15.91
TBVpS5.05
PEG (NY)1.44
PEG (5Y)N/A
Graham Number11.66
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.21% | ||
| ROE | 2.4% | ||
| ROCE | 3.75% | ||
| ROIC | 2.96% | ||
| ROICexc | 4.13% | ||
| ROICexgc | 54.36% | ||
| OM | 9.81% | ||
| PM (TTM) | 6.1% | ||
| GM | 68.53% | ||
| FCFM | 19.84% |
ROA(3y)-2.65%
ROA(5y)-4.39%
ROE(3y)-2.82%
ROE(5y)-4.73%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.39%
GM growth 5Y-0.79%
F-Score8
Asset Turnover0.36
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 44.32% | ||
| Cap/Sales | 1.97% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 153.06% | ||
| Profit Quality | 325.55% | ||
| Current Ratio | 6.24 | ||
| Quick Ratio | 5.96 | ||
| Altman-Z | 18.51 |
F-Score8
WACC8.82%
ROIC/WACC0.34
Cap/Depr(3y)39.23%
Cap/Depr(5y)36.18%
Cap/Sales(3y)2.7%
Cap/Sales(5y)2.6%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)353.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%26.32%
EPS Next Y76.8%
EPS Next 2Y87.27%
EPS Next 3Y59.79%
EPS Next 5Y51.21%
Revenue 1Y (TTM)16.41%
Revenue growth 3Y26.64%
Revenue growth 5Y29.93%
Sales Q2Q%13.82%
Revenue Next Year14.5%
Revenue Next 2Y12.7%
Revenue Next 3Y12.38%
Revenue Next 5Y11.52%
EBIT growth 1Y433.57%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year319.96%
EBIT Next 3Y74.15%
EBIT Next 5Y48.27%
FCF growth 1Y237.75%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y181.1%
OCF growth 3YN/A
OCF growth 5YN/A
VERACYTE INC / VCYT FAQ
What is the fundamental rating for VCYT stock?
ChartMill assigns a fundamental rating of 6 / 10 to VCYT.
What is the valuation status of VERACYTE INC (VCYT) stock?
ChartMill assigns a valuation rating of 6 / 10 to VERACYTE INC (VCYT). This can be considered as Fairly Valued.
How profitable is VERACYTE INC (VCYT) stock?
VERACYTE INC (VCYT) has a profitability rating of 6 / 10.
Can you provide the PE and PB ratios for VCYT stock?
The Price/Earnings (PE) ratio for VERACYTE INC (VCYT) is 110.63 and the Price/Book (PB) ratio is 2.64.
What is the financial health of VERACYTE INC (VCYT) stock?
The financial health rating of VERACYTE INC (VCYT) is 8 / 10.